Valens
Ownership
Ownership Structure
Who owns Valens (VLN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.0% of the shares are freely tradable; institutional investors hold 37.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Value Base Ltd. | 19.85 | 21,491,922 | +0.1 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 2.22 | 2,401,143 | +31.3 | 06/30/2026 |
| State Street Corp | 2.04 | 2,213,690 | +0.0 | 06/30/2026 |
| Clal Insurance Enterprises Holdings Ltd | 1.83 | 1,984,537 | +0.0 | 06/30/2026 |
| Ameriprise Financial Inc | 1.55 | 1,682,042 | +12.4 | 06/30/2026 |
| Renaissance Technologies Corp | 1.36 | 1,468,229 | +11.9 | 06/30/2026 |
| ARK Investment Management LLC | 1.30 | 1,412,570 | +34.7 | 06/30/2026 |
| Two Sigma Investments LLC | 0.90 | 971,883 | +429.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 1.96 | 2,116,833 | +0.1 | 10/30/2026 |
| ARK Israel Innovative Technology ETF | 1.13 | 1,220,746 | +0.0 | 10/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Chairman David | SVP, R&D | 403,968 | 605,952 $ | Nov 11, 2026 | direct |
| Rozenberg Haine Yael | VP Finance | 129,359 | 194,039 $ | Nov 9, 2026 | direct |
| Lichtman Moshe | Director | 118,950 | 178,425 $ | Oct 13, 2026 | indirect |
| Yaacobi Tal | Director | 63,348 | 95,022 $ | Oct 13, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Chairman David | SVP, R&D | Sell | 278 | 1.66 | 461 |
| Nov 11, 2026 | Chairman David | SVP, R&D | Other | 278 | 0.86 | 239 |
| Nov 10, 2026 | Chairman David | SVP, R&D | Sell | 3,235 | 1.66 | 5,381 |
| Nov 10, 2026 | Chairman David | SVP, R&D | Other | 3,235 | 0.86 | 2,782 |
| Nov 9, 2026 | Rozenberg Haine Yael | VP Finance | Sell | 625 | 1.50 | 938 |
| Oct 23, 2026 | Rozenberg Haine Yael | VP Finance | Sell | 2,750 | 1.52 | 4,178 |
| Oct 22, 2026 | Rozenberg Haine Yael | VP Finance | Sell | 3,125 | 1.54 | 4,803 |
| Oct 19, 2026 | Rozenberg Haine Yael | VP Finance | Sell | 1,458 | 1.62 | 2,364 |
| Oct 13, 2026 | Lichtman Moshe | Director | Sell | 3,750 | 1.64 | 6,150 |
| Oct 13, 2026 | Yaacobi Tal | Director | Sell | 3,750 | 1.64 | 6,150 |
| Oct 1, 2026 | Yaacobi Tal | Director | Sell | 1,400 | 1.89 | 2,646 |
| Apr 22, 2026 | David Chairman | SVP | Sell | 400 | 1.65 | 660 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.